A 45-year-old male with a history of opioid use disorder (in remission for 2 years on buprenorphine maintenance) undergoes open abdominal surgery. Postoperatively, he is prescribed patient-controlled analgesia (PCA) with morphine. Within 2 hours of initiation, he develops acute respiratory depression (RR 8/min, SpO₂ 88%) and severe sedation. Which of the following is the MOST likely mechanism underlying this adverse event?

Explanation

## Mechanism of Opioid Toxicity in Buprenorphine-Maintained Patients **Key Point:** Buprenorphine is a partial mu-receptor agonist with exceptionally high receptor binding affinity (Kd ~0.1 nM) and slow dissociation kinetics. When a patient on buprenorphine maintenance receives a full mu-receptor agonist like morphine via PCA, the morphine cannot effectively displace buprenorphine from the mu receptor due to buprenorphine's superior binding characteristics. **Clinical Pearl:** This creates a dual problem: 1. **Inadequate opioid receptor occupancy by morphine** — morphine cannot achieve sufficient mu-receptor activation because buprenorphine occupies the receptor sites 2. **Acute opioid toxicity from PCA boluses** — the patient's tolerance is calibrated to buprenorphine's partial agonist effect; the morphine boluses, even if they cannot fully displace buprenorphine, add to the overall opioid burden and exceed the patient's physiologic tolerance, resulting in respiratory depression and sedation **High-Yield:** The respiratory depression observed here is NOT due to synergistic pharmacodynamic interaction in the traditional sense, but rather from: - Morphine boluses overwhelming the patient's tolerance ceiling (which is lower than in opioid-naive patients but lower than in patients on full-agonist opioids) - Buprenorphine's ceiling effect on respiratory depression being exceeded when additional morphine is added **Management principle:** PCA with morphine is contraindicated in buprenorphine-maintained patients. Regional anesthesia, non-opioid analgesics, or continuation of buprenorphine with careful titration of supplemental full-agonist opioids (if absolutely necessary) under close monitoring is preferred. **Mnemonic:** **BuPre-MorPh = Problem** — Buprenorphine's partial agonism + morphine's full agonism in the same patient = respiratory depression paradox.